Skip to main content
. 2020 Jan 15;21(2):565. doi: 10.3390/ijms21020565
VEGF Vascular endothelial growth factor
TSP Thrombospondins
PGF Placental growth factor
VEGFR Vascular endothelial growth factor receptors
SCLC Small cell lung cancer
NSCLC Non-small cell lung cancer
TKI Tyrosine kinase inhibitor
OS Overall survival
PFS Progression free survival
HIF-1 Hypoxia-inducible factor
pCR Pathologic complete response
DFS Disease-free survival
PDGF Platelet-derived growth factor receptor
FLT3 Fms-related tyrosine kinase 3
PD-L1 Programmed death- ligand 1
HDAC Histone deacetylase
SAHA Suberanilohydroxamic acid
TSA Trichostatin A
NP1 Neuropilin1
NP2 Neuropilin2
miRs MicroRNAs
EGCG Epigallocatechin-3-O-gallate
PFKFB3 Phosphofruktokinase-2/fructose-2,6-bisphosphatase 3
MCT4 Monocarboxylate transporter 4
ATP Adenosine triphosphate
MMP Matrix metalloproteinase
TAM Tumor-associated macrophages
TEM TIE2 expressing macrophages
HSP Heparin sulfate proteoglycan
bFGF basic fibroblast growth factor
FGFR Fibroblast growth factor receptor
IL-6 Interleukin-6
EC Endothelial cells
VM Vascular mimicry
VE-cadherin Vascular endothelial cadherin
PECAM Platelet EC adhesion molecule
PA Plasminogen Activator
MCT4 Monocarboxylate transporter 4
EMT Epithelial mesenchymal transition
EGFR Epidermal growth factor receptor